uBiome, Inc., announced that it has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in Delaware to facilitate an orderly and efficient sale of its ongoing business, products in development, technology, and […]
A group of University of California, Irvine scientists believes a clue to withstanding climate change could be lurking in fields near their campus. Now the research team from UCI’s School of Biological Sciences and Department […]
Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint […]
The pathogen Clostridium difficile, which causes one of the most common hospital-acquired infections in the United States, may have accomplices that until now have gone largely unnoticed. This week in mSphere, researchers report finding fungi […]
BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, announced completion of construction of a new state-of-the-art manufacturing facility. The new facility is located at the company’s headquarters in Ness Ziona and […]
How many stars are there in the observable universe? It was once deemed an impossible question, but astronomers have gleaned an answer–about one billion trillion of them. Now, scientists at Harvard Medical School and Joslin […]
Poo transplants are helping expand koala microbiomes, allowing the marsupials to eat a wider range of eucalypts and possibly survive habitat loss. A study featuring University of Queensland researchers has analysed and altered microbes in […]
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced the completion of a $53 million Series C financing. The financing comes from new investors including OCV Partners, Susquehanna International Group (SIG), Symbiosis LLC and […]
The National Microbiome Data Collaborative (NMDC), a new initiative aimed at empowering microbiome research, is gearing up its pilot phase after receiving $10 million from the U.S. Department of Energy (DOE) Office of Science. Spearheaded […]
A key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes all treatments is the bacterial signatures on their tumors that either stimulate or suppress immune response, a […]
Corteva, Inc. (NYSE: CTVA), a leading pure-play agriculture company, and Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that Corteva will make an investment in […]